Testing our drugs on the poor abroad

Determining whether US companies and some of the persons involved in them are acting ethically when conducting the research described in the Havrix Case and the Surfaxin Trial requires reflection on the moral objections that could be raised against what they did. Given the wide range of possible moral objections, it would be folly to try to display and discuss them all in the space of this essay. I concentrate then on a kind of moral objections that strike me as especially interesting, plausible, and important. I try to work out whether such objections are valid and, if so, what significance they have for the conduct of the pharmaceutical companies in question — and for the conduct of ourselves as citizens of democratic countries under whose jurisdiction these companies operate.
Keywords No keywords specified (fix it)
Categories No categories specified
(categorize this paper)
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
Download options
PhilPapers Archive

Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 9,351
External links
  •   Try with proxy.
  • Through your library Only published papers are available at libraries
    References found in this work BETA

    No references found.

    Citations of this work BETA

    No citations found.

    Similar books and articles

    Monthly downloads

    Added to index


    Total downloads

    99 ( #9,099 of 1,088,398 )

    Recent downloads (6 months)

    3 ( #30,936 of 1,088,398 )

    How can I increase my downloads?

    My notes
    Sign in to use this feature

    Start a new thread
    There  are no threads in this forum
    Nothing in this forum yet.